← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Retractable Technologies, Inc. (RVP) 10-Year Financial Performance & Capital Metrics

RVP • • Industrial / General
HealthcareMedical InstrumentsMedical Consumables & DisposablesSafety Syringes & Injectables
AboutRetractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Show more
  • Revenue $33M -24.2%
  • EBITDA -$14M -241.7%
  • Net Income -$12M -69.5%
  • EPS (Diluted) -0.40 -66.7%
  • Gross Margin -3.11% -114.9%
  • EBITDA Margin -40.96% -350.8%
  • Operating Margin -63.86% -142.3%
  • Net Margin -35.97% -123.6%
  • ROE -12.75% -87.2%
  • ROIC -18.37% -89.6%
  • Debt/Equity 0.01 -8.7%
  • Interest Coverage -172.29 -128.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Trading at only 0.2x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.43%
5Y-4.59%
3Y-44.02%
TTM-0.24%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM51.09%

EPS CAGR

10Y-
5Y-
3Y-
TTM50.67%

ROCE

10Y Avg5.09%
5Y Avg15.83%
3Y Avg-6.59%
Latest-13.1%

Peer Comparison

Safety Syringes & Injectables
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
UTMDUtah Medical Products, Inc.193.09M60.2715.22-18.56%32.33%10.68%7.56%0.00
STSSSharps Technology, Inc.66.69M2.30-0.00-324.78%-4.98%1.89
RVPRetractable Technologies, Inc.21.26M0.71-1.78-24.19%-22.9%-11.43%0.01
XRAYDENTSPLY SIRONA Inc.2.51B12.58-2.81-4.34%-24.34%-59.68%11.19%1.17
ZTEKZentek Ltd.93.36M0.87-8.7028.26%-8.95%-70.13%0.05

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+29.55M29.83M34.49M33.27M41.8M81.86M188.38M94.82M43.6M33.05M
Revenue Growth %-0.14%0.01%0.16%-0.04%0.26%0.96%1.3%-0.5%-0.54%-0.24%
Cost of Goods Sold+18.99M19.48M24.52M23.05M27.66M44.85M93.03M66.57M34.49M34.08M
COGS % of Revenue0.64%0.65%0.71%0.69%0.66%0.55%0.49%0.7%0.79%1.03%
Gross Profit+10.57M10.34M9.97M10.22M14.14M37.01M95.35M28.25M9.11M-1.03M
Gross Margin %0.36%0.35%0.29%0.31%0.34%0.45%0.51%0.3%0.21%-0.03%
Gross Profit Growth %-0.12%-0.02%-0.04%0.03%0.38%1.62%1.58%-0.7%-0.68%-1.11%
Operating Expenses+13.77M13.39M13.75M11.8M11.17M12.94M22.76M29.11M20.6M20.08M
OpEx % of Revenue0.47%0.45%0.4%0.35%0.27%0.16%0.12%0.31%0.47%0.61%
Selling, General & Admin13.17M12.82M13.01M11.18M10.65M12.36M21.86M28.58M20.01M19.4M
SG&A % of Revenue0.45%0.43%0.38%0.34%0.25%0.15%0.12%0.3%0.46%0.59%
Research & Development607.53K571.84K740.57K621.37K516.1K574.53K901.38K525.73K581.17K673.94K
R&D % of Revenue0.02%0.02%0.02%0.02%0.01%0.01%0%0.01%0.01%0.02%
Other Operating Expenses0000000000
Operating Income+-3.21M-3.51M-3.78M-1.32M2.97M24.07M72.6M-852.98K-11.49M-21.11M
Operating Margin %-0.11%-0.12%-0.11%-0.04%0.07%0.29%0.39%-0.01%-0.26%-0.64%
Operating Income Growth %-0.49%-0.09%-0.08%0.65%3.25%7.1%2.02%-1.01%-12.47%-0.84%
EBITDA+-2.35M-2.63M-2.94M-433.38K3.82M24.9M73.85M3.75M-3.96M-13.54M
EBITDA Margin %-0.08%-0.09%-0.09%-0.01%0.09%0.3%0.39%0.04%-0.09%-0.41%
EBITDA Growth %-1.17%-0.12%-0.12%0.85%9.82%5.51%1.97%-0.95%-2.06%-2.42%
D&A (Non-Cash Add-back)858.39K872.87K834.95K886.81K852.08K832.07K1.26M4.6M7.53M7.57M
EBIT4.54M-3.48M-3.71M-1.18M3.32M26.33M75.18M5.33M-8.76M-3.4M
Net Interest Income+-194.75K-186.77K-145.07K-23.73K184.27K132.48K39.28K-160.7K1.29M877.93K
Interest Income24.92K26.52K65.69K153.46K351.17K392.75K266.47K9.95K1.45M1M
Interest Expense219.67K213.29K210.76K177.19K166.9K260.26K227.18K170.65K152.17K122.5K
Other Income/Expense7.53M-642.89K-145.07K236.78K184.27K2M2.36M6.02M2.57M17.59M
Pretax Income+4.32M-3.69M-3.92M-1.35M3.16M26.07M74.95M5.16M-8.92M-3.52M
Pretax Margin %0.15%-0.12%-0.11%-0.04%0.08%0.32%0.4%0.05%-0.2%-0.11%
Income Tax+7.88K1.13K-187.61K-13.32K7.88K1.85M18.89M83.87K-1.91M8.37M
Effective Tax Rate %1%1%0.95%0.99%1%0.93%0.75%0.98%0.79%3.38%
Net Income+4.31M-3.69M-3.74M-1.34M3.15M24.22M56.06M5.08M-7.01M-11.89M
Net Margin %0.15%-0.12%-0.11%-0.04%0.08%0.3%0.3%0.05%-0.16%-0.36%
Net Income Growth %2.83%-1.86%-0.01%0.64%3.35%6.69%1.31%-0.91%-2.38%-0.7%
Net Income (Continuing)4.31M-3.69M-3.74M-1.34M3.15M24.22M56.06M5.08M-7.01M-11.89M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)+0.20-0.13-0.12-0.040.070.801.630.15-0.24-0.40
EPS Growth %3.33%-1.65%0.08%0.66%2.82%9.7%1.04%-0.91%-2.6%-0.67%
EPS (Basic)0.21-0.13-0.12-0.040.070.801.650.15-0.24-0.40
Diluted Shares Outstanding29.48M29.35M31.96M32.67M32.67M33.3M34.24M32.96M29.94M29.94M
Basic Shares Outstanding27.82M29.33M31.72M32.67M32.67M33.17M33.87M32.9M29.94M29.94M
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+30.81M26.68M26.61M23.85M28.41M69.48M104.51M88.81M77.65M73.27M
Cash & Short-Term Investments18.05M16.2M14.88M10.64M13.71M25.65M42.43M49.38M47.29M44.56M
Cash Only18.05M16.2M14.88M9.65M5.93M17.57M29.16M19.72M12.67M4.24M
Short-Term Investments000996.23K7.77M8.08M13.27M29.66M34.62M40.33M
Accounts Receivable4.9M3.27M5.11M5.01M6.61M32.91M40.78M17.48M11.83M8.77M
Days Sales Outstanding60.5339.9954.0254.9957.76146.7479.0267.2999.0296.81
Inventory6.3M7.02M6.21M7.55M7.45M10.23M20.59M20.68M17.58M19.19M
Days Inventory Outstanding121.04131.4592.38119.4698.3283.2880.78113.42186.06205.54
Other Current Assets1.57M192.55K418.15K644.8K635.2K684.32K701.97K1.26M952.67K753.06K
Total Non-Current Assets+11.73M12.1M11.55M12.95M17.43M35.49M108.65M121.93M102.02M87.45M
Property, Plant & Equipment11.47M12.09M11.35M10.85M10.71M30.82M87.93M100.15M93.48M87.35M
Fixed Asset Turnover2.58x2.47x3.04x3.07x3.90x2.66x2.14x0.95x0.47x0.38x
Goodwill0000000000
Intangible Assets257.18K000000000
Long-Term Investments0001.99M50.39K00000
Other Non-Current Assets4.92K10.29K194.51K103.68K5.96K44.57K5.67K184.52K152.06K103.63K
Total Assets+42.54M38.78M38.16M36.79M45.84M104.97M213.15M210.74M179.67M160.72M
Asset Turnover0.69x0.77x0.90x0.90x0.91x0.78x0.88x0.45x0.24x0.21x
Asset Growth %-0.06%-0.09%-0.02%-0.04%0.25%1.29%1.03%-0.01%-0.15%-0.11%
Total Current Liabilities+8.1M7.17M7.9M8.54M8.26M27.9M35.32M12.14M9.38M8.78M
Accounts Payable5.7M4.47M4.96M5.37M5.01M16.26M20.4M6.4M4.78M4.29M
Days Payables Outstanding109.5383.7773.7985.0266.08132.2980.0635.1250.5845.96
Short-Term Debt249.35K430.39K410.95K406.36K343.3K1.03M1.39M1.38M303.99K332.48K
Deferred Revenue (Current)395.4K692.92K355.74K860.93K998.6K1000K1000K435.92K201.49K376.56K
Other Current Liabilities1.38M1.72M1.62M540.85K1.28M826.76K5.18M2.85M865.11K1.07M
Current Ratio3.81x3.72x3.37x2.79x3.44x2.49x2.96x7.32x8.28x8.34x
Quick Ratio3.03x2.74x2.58x1.91x2.54x2.12x2.38x5.61x6.41x6.16x
Cash Conversion Cycle72.0587.6772.6189.449097.7479.75145.59234.5256.39
Total Non-Current Liabilities+3.42M3.5M3.08M2.64M9.04M27.19M78.66M92.07M71.01M64.77M
Long-Term Debt3.42M3.5M3.08M2.64M2.38M2.71M2.85M1.53M1.23M900.04K
Capital Lease Obligations0000000000
Deferred Tax Liabilities0007.43M6.66M2.19M6.85M15.08M00
Other Non-Current Liabilities00082.36K024.48M68.96M75.46M69.77M63.87M
Total Liabilities11.51M10.67M10.98M11.18M17.29M55.09M113.98M104.21M80.38M73.55M
Total Debt+3.67M3.93M3.49M3.05M2.72M3.74M4.24M2.92M1.54M1.23M
Net Debt-14.38M-12.27M-11.39M-6.6M-3.21M-13.83M-24.92M-16.8M-11.13M-3M
Debt / Equity0.12x0.14x0.13x0.12x0.10x0.08x0.04x0.03x0.02x0.01x
Debt / EBITDA----0.71x0.15x0.06x0.78x--
Net Debt / EBITDA-----0.84x-0.56x-0.34x-4.48x--
Interest Coverage-14.60x-16.44x-17.93x-7.45x17.81x92.49x319.54x-5.00x-75.50x-172.29x
Total Equity+31.03M28.11M27.17M25.61M28.54M49.88M99.17M106.54M99.29M87.17M
Equity Growth %0.16%-0.09%-0.03%-0.06%0.11%0.75%0.99%0.07%-0.07%-0.12%
Book Value per Share1.050.960.850.780.871.502.903.233.322.91
Total Shareholders' Equity31.03M28.11M27.17M25.61M28.54M49.88M99.17M106.54M99.29M87.17M
Common Stock0000000000
Retained Earnings-28.02M-31.96M-35.7M-37.04M-33.89M-9.67M41.18M46.03M38.79M26.67M
Treasury Stock000000-5.27M-12.89M-12.89M-12.89M
Accumulated OCI-22.09M-22.95M-23.78M-24.67M000000
Minority Interest0000000000

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-3.25M-794.91K-2.92M-1.2M2.19M19M32.79M16.77M2.77M-11.56M
Operating CF Margin %-0.11%-0.03%-0.08%-0.04%0.05%0.23%0.17%0.18%0.06%-0.35%
Operating CF Growth %0.16%0.76%-2.68%0.59%2.84%7.66%0.73%-0.49%-0.83%-5.18%
Net Income4.31M-3.69M-3.74M-1.34M3.15M24.22M56.06M5.08M-7.01M-11.89M
Depreciation & Amortization858.39K872.87K834.95K886.81K852.08K832.07K1.26M4.6M7.53M7.57M
Stock-Based Compensation0387.73K672.22K0003.66M10.13M00
Deferred Taxes0548.12K000-4.63M-9.23M7.35M-1.87M8.39M
Other Non-Cash Items-7.61M176.42K24.27K-249.94K-137.24K-1.94M-1.63M-5.47M-467.04K-16.14M
Working Capital Changes-816.43K914.86K-718.04K-492.43K-1.67M513.18K-17.32M-4.92M4.59M504.16K
Change in Receivables624.7K1.54M-1.86M145.41K-1.65M-14.63M-13.88M29.7M3M2.49M
Change in Inventory-1.63M-897.02K811.06K-1.04M94.5K-2.78M-10.36M-94.25K2.93M-1.61M
Change in Payables554.72K-1.23M485.99K411.93K-362.07K11.25M4.15M-14M-1.63M-488.45K
Cash from Investing+-864.11K-1.95M-91.88K-3.37M-5.28M-19.33M-63.04M-31.2M-10.76M3.66M
Capital Expenditures-1.47M-1.95M-91.88K-382.16K-632.08K-21.05M-58.37M-16.83M-852.98K-1.44M
CapEx % of Revenue0.05%0.07%0%0.01%0.02%0.26%0.31%0.18%0.02%0.04%
Acquisitions----------
Investments----------
Other Investing600.9K00-2.99M-4.65M1.72M-4.67M-3.76M00
Cash from Financing+32.34K896.08K1.69M-666.8K-626.84K11.96M41.84M4.99M941.64K-535.43K
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid-283.54K-220.75K-220.45K-220.45K-219.82K-216.64K-3.82M-252.88K-232.44K-230.44K
Share Repurchases----------
Other Financing223.83K855.02K00011.56M52.41M14.25M2.56M0
Net Change in Cash----------
Free Cash Flow+-4.72M-2.74M-3.01M-1.58M1.56M-2.05M-25.57M-61.95K1.91M-13M
FCF Margin %-0.16%-0.09%-0.09%-0.05%0.04%-0.03%-0.14%-0%0.04%-0.39%
FCF Growth %0.03%0.42%-0.1%0.48%1.99%-2.31%-11.46%1%31.89%-7.79%
FCF per Share-0.16-0.09-0.09-0.050.05-0.06-0.75-0.000.06-0.43
FCF Conversion (FCF/Net Income)-0.75x0.22x0.78x0.89x0.70x0.78x0.58x3.30x-0.39x0.97x
Interest Paid219.67K213.29K210.76K177.19K0260.26K118.16K110.54K00
Taxes Paid3.7K2K1.03K1.17K02.11M27.12M12.32M00

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)14.91%-12.5%-13.52%-5.08%11.63%61.78%75.23%4.94%-6.81%-12.75%
Return on Invested Capital (ROIC)-19.31%-16.19%-17.92%-5.69%10.05%58.82%98.72%-0.78%-9.69%-18.37%
Gross Margin35.75%34.67%28.91%30.72%33.83%45.21%50.62%29.8%20.89%-3.11%
Net Margin14.6%-12.39%-10.83%-4.03%7.53%29.59%29.76%5.36%-16.08%-35.97%
Debt / Equity0.12x0.14x0.13x0.12x0.10x0.08x0.04x0.03x0.02x0.01x
Interest Coverage-14.60x-16.44x-17.93x-7.45x17.81x92.49x319.54x-5.00x-75.50x-172.29x
FCF Conversion-0.75x0.22x0.78x0.89x0.70x0.78x0.58x3.30x-0.39x0.97x
Revenue Growth-14.39%0.93%15.65%-3.53%25.61%95.86%130.12%-49.67%-54.02%-24.19%

Revenue by Segment

2015201620172018201920202021202220232024
License---------189K
License Growth----------
Other Products---------45.85K
Other Products Growth----------
Other international sales-------13.47M2.91M-
Other international sales Growth---------78.38%-

Revenue by Geography

2015201620172018201920202021202220232024
North and South America (excluding U.S)------14.56M---
North and South America (excluding U.S) Growth----------
North And South America Excluding United States5.67M2.74M6.38M3.52M7.86M5.73M----
North And South America Excluding United States Growth--51.64%132.74%-44.81%123.29%-27.09%----
U23.03M26.31M27.02M23.8M26.72M-----
U Growth-14.23%2.69%-11.89%12.26%-----

Frequently Asked Questions

Growth & Financials

Retractable Technologies, Inc. (RVP) reported $38.2M in revenue for fiscal year 2024. This represents a 19% increase from $32.1M in 2011.

Retractable Technologies, Inc. (RVP) saw revenue decline by 24.2% over the past year.

Retractable Technologies, Inc. (RVP) reported a net loss of $8.7M for fiscal year 2024.

Dividend & Returns

Yes, Retractable Technologies, Inc. (RVP) pays a dividend with a yield of 1.08%. This makes it attractive for income-focused investors.

Retractable Technologies, Inc. (RVP) has a return on equity (ROE) of -12.7%. Negative ROE indicates the company is unprofitable.

Retractable Technologies, Inc. (RVP) had negative free cash flow of $13.6M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.